Key statistics
As of last trade, Bruker Corp (BKD:STU) traded at 33.78, 36.10% above the 52 week low of 24.82 set on Sep 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 34.30 |
|---|---|
| High | 34.46 |
| Low | 33.78 |
| Bid | 33.85 |
| Offer | 34.04 |
| Previous close | 34.61 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 151.94m |
| Free float | 103.36m |
| P/E (TTM) | -- |
| Market cap | 6.09bn USD |
| EPS (TTM) | -0.1487 USD |
| Annual div (ADY) | 0.1719 EUR |
|---|---|
| Annual div yield (ADY) | 0.51% |
| Div ex-date | Dec 08 2025 |
| Div pay-date | Jan 02 2026 |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Press releases
- Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
- Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
- Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
- Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
- Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
- Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
- Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
- Bruker Announces Quarterly Preferred Stock Dividend
- Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
- Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI
More ▼
